Treace Medical Concepts (TMCI) investor relations material

Future Plans, Strategic Vision, and Market Opportunity

• Launching a comprehensive bunion solutions portfolio, including new systems such as Nanoplasty, Percuplasty 3D MIS osteotomy, SpeedMTP Rapid Compression Implant, Micro-Lapiplasty, Mini-Adductoplasty, and IntelliGuide PSI, to access untapped market segments and broaden surgeon appeal.

• Targeting to double business in the coming years by increasing market penetration from 3% to 7-8% of symptomatic surgical candidates, leveraging both current and pipeline technologies.

• US bunion market opportunity exceeds $5B, with over 1.1 million surgical candidates and 450,000 procedures annually.

• Five-year revenue CAGR of 40% and FY2024 revenue of $209.4M (+12%), with gross margin at 80%.

• Portfolio expansion aims to make the company a “one-stop-shop” for bunion cases, addressing mild to severe deformities and adjacent procedures.

Product Innovation and Pipeline

• Five key growth drivers: advancing core procedures, expanding into adjacent procedures, growing MIS systems, scaling SpeedPlate platform, and developing PSI digital solutions.

• Launch of highly instrumented systems (Nanoplasty, Percuplasty) and digital/AI-driven solutions to reduce the learning curve and enable personalized, pre-planned surgeries.

• SpeedPlate and SpeedMTP platforms offer rapid, dynamic compression and fatigue-resistant fixation, supporting faster recovery and broader application across foot pathologies.

• Iterative innovation reduces incision size (from 7cm to 2cm) and improves efficiency, reproducibility, and outcomes.

• Pipeline includes differentiated solutions for adjacent reconstructive procedures, such as Akinator, SpeedAkin, and flat foot correction.

Market Expansion and Growth Drivers

• Nearly one-third of all bunion surgeons expected to adopt Lapiplasty by 2025, with current penetration at about 30% of total bunion volume among 3,100 surgeon customers.

• Accelerating access to 3D minimally invasive solutions with systems designed to reduce the learning curve for surgeons.

• Surgeons expect MIS osteotomies to be the fastest-growing bunion procedure segment in the next year.

• Enabling technologies and digital solutions are positioned to capture a larger share of the growing bunion and midfoot deformity market.

• Focus on reproducibility, efficiency, and less-invasive approaches to increase adoption and market penetration.